<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pmed.1002882.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pmed.1002882.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>FDA/WHO pregnancy classification and select maternal–fetal and reproductive toxicity characteristics of drugs used to treat TB.</title>
 </caption>
 <alternatives>
  <graphic id="pmed.1002882.t001g" xlink:href="pmed.1002882.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Drug Name</th>
     <th align="left" rowspan="1" colspan="1">FDA
      <xref ref-type="table-fn" rid="t001fn002">
       <sup>a</sup>
      </xref>
     </th>
     <th align="left" rowspan="1" colspan="1">WHO Grouping
      <xref ref-type="table-fn" rid="t001fn004">
       <sup>b</sup>
      </xref>
     </th>
     <th align="left" rowspan="1" colspan="1">Crosses Placenta (Cord: Maternal Ratio)</th>
     <th align="left" rowspan="1" colspan="1">Fetal Toxicity</th>
     <th align="left" rowspan="1" colspan="1">Breastfeeding Compatible
      <xref ref-type="table-fn" rid="t001fn004">
       <sup>b</sup>
      </xref>
     </th>
     <th align="left" rowspan="1" colspan="1">Teratogenic in Reproductive Toxicity Studies</th>
     <th align="left" rowspan="1" colspan="1">Additional Concerns in Pregnancy and Postpartum</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">Isoniazid</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">1</td>
     <td align="left" rowspan="1" colspan="1">Y</td>
     <td align="left" rowspan="1" colspan="1">CNS defects</td>
     <td align="left" rowspan="1" colspan="1">Yes (&lt;5%)</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">Possible increased hepatotoxicity</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Rifampin</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">1</td>
     <td align="left" rowspan="1" colspan="1">Y</td>
     <td align="left" rowspan="1" colspan="1">Hemorrhage</td>
     <td align="left" rowspan="1" colspan="1">Yes (minimal passage, approximately 0.05% to &lt;5%)</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Possible postpartum hemorrhage; interacts with NNRTIs, PIs, decreases efficacy of hormonal contraceptives</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Ethambutol</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">1/C</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Jaundice</td>
     <td align="left" rowspan="1" colspan="1">UD (minimal passage, &lt;5%)</td>
     <td align="left" rowspan="1" colspan="1">Yes (low incidence)</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Pyrazinamide</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">1/C</td>
     <td align="left" rowspan="1" colspan="1">Unknown</td>
     <td align="left" rowspan="1" colspan="1">Jaundice</td>
     <td align="left" rowspan="1" colspan="1">UD (excreted in breast milk)</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Differential recommendation between US CDC and WHO for use in TB treatment in pregnancy</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Rifabutin</td>
     <td align="left" rowspan="1" colspan="1">B</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">Possible postpartum hemorrhage; interacts with NNRTIs, PIs, decreases efficacy of hormonal contraceptives</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Rifapentine</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Possible postpartum hemorrhage; interacts with NNRTIs, PIs, decreases efficacy of hormonal contraceptives</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Aminoglycosides</td>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">    Capreomycin</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">Not A–C</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">    Streptomycin</td>
     <td align="left" rowspan="1" colspan="1">D</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Ototoxicity, thrush, diarrhea</td>
     <td align="left" rowspan="1" colspan="1">Yes (minimal passage)</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">    Kanamycin</td>
     <td align="left" rowspan="1" colspan="1">D</td>
     <td align="left" rowspan="1" colspan="1">Not A–C</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Ototoxicity</td>
     <td align="left" rowspan="1" colspan="1">Yes (minimal passage)</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">    Amikacin</td>
     <td align="left" rowspan="1" colspan="1">D</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Ototoxicity</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Levofloxacin</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">A</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Possible bone</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Moxifloxacin</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">A</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Possible bone</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Gatifloxacin</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">Not A–C</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Possible bone</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Ethionamide/prothionamide</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Developmental anomalies</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Developmental abnormalities in human case series</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">P-aminosalicylic acid</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Diarrhea</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Cycloserine</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">B</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Congenital sideroblastic anemia</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Terizidone</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">B</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Thioacetazone</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">Not A–C</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Clofazimine</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">B</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Reversible skin pigmentation</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Clarithromycin</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">Not A–C</td>
     <td align="left" rowspan="1" colspan="1">Yes (0.15)</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Amoxicillin-clavulanic acid</td>
     <td align="left" rowspan="1" colspan="1">B</td>
     <td align="left" rowspan="1" colspan="1">Not A–C</td>
     <td align="left" rowspan="1" colspan="1">Yes (0.56)</td>
     <td align="left" rowspan="1" colspan="1">Necrotizing enterocolitis, transaminitis</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Linezolid</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">A</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">Case report of reduced PK in pregnancy</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Imipenem/meropenem</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">–</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">High-dose isoniazid</td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">Not A–C</td>
     <td align="left" rowspan="1" colspan="1">Yes (0.73)</td>
     <td align="left" rowspan="1" colspan="1">CNS defects</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">Possible hepatotoxicity</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Bedaquiline</td>
     <td align="left" rowspan="1" colspan="1">B</td>
     <td align="left" rowspan="1" colspan="1">A</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">No</td>
     <td align="left" rowspan="1" colspan="1">Drug accumulation in tissues</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Delamanid</td>
     <td align="left" rowspan="1" colspan="1">Not approved
      <sup>c</sup>
     </td>
     <td align="left" rowspan="1" colspan="1">C</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Embryofetal toxicity at maternally toxic doses in rabbits; breast milk concentration 4× higher than blood in rats</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Pretomanid</td>
     <td align="left" rowspan="1" colspan="1">Not approved</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Sutezolid</td>
     <td align="left" rowspan="1" colspan="1">Not approved</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">–</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1">UD</td>
     <td align="left" rowspan="1" colspan="1"/>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>Table adapted from [
    <xref rid="pmed.1002882.ref006" ref-type="bibr">6</xref>].
   </p>
  </fn>
  <fn id="t001fn002">
   <p>
    <sup>a</sup> The former FDA categories were defined as follows: category A: adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters); category B: animal reproduction studies have failed to demonstrate a risk to the fetus, and there are no adequate and well-controlled studies in pregnant women; category C: animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks; category D: there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks; category X: studies in animals or humans have demonstrated fetal abnormalities, and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits. The US FDA now uses narrative summaries to communicate what information is known and not known for individual drugs. However, the former risk categorization is still felt to be useful and has been used in this table. 
    <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/about-fda/economic-impact-analyses-fda-regulations/summary-content-and-format-labeling-human-prescription-drug-and-biological-products-requirements" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/about-fda/economic-impact-analyses-fda-regulations/summary-content-and-format-labeling-human-prescription-drug-and-biological-products-requirements</ext-link>.
   </p>
  </fn>
  <fn id="t001fn003">
   <p>Additional information about each drug can be found at 
    <ext-link ext-link-type="uri" xlink:href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm</ext-link>.
   </p>
  </fn>
  <fn id="t001fn004">
   <p>
    <sup>b</sup> Information on breast milk transfer of TB drugs is collated on LactMed, the National Library of Medicine searchable database of drugs to which breastfeeding mothers may be exposed. 
    <ext-link ext-link-type="uri" xlink:href="https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm" xmlns:xlink="http://www.w3.org/1999/xlink">https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm</ext-link>.
   </p>
  </fn>
  <fn id="t001fn005">
   <p>
    <sup>c</sup> Approved by European Medicine Association and other non-FDA agencies outside the US.
   </p>
  </fn>
  <fn id="t001fn006">
   <p>Abbreviations: CDC, Centers for Disease Control and Prevention; CNS, central nervous system; FDA, Food and Drug Administration; NNRTI, nonnucleoside reverse transcriptase inhibitor; PI, protease inhibitor; PK, pharmacokinetics; UD, undetermined; WHO, World Health Organization</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
